ARCHIVES

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

NCI-Approved Clinical Trials

September 28, 2001

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

November 30, 2001

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987